Jiemian News learned from cross-confirmation from multiple channels that ShandongWohua PharmaceuticalTechnology Co., Ltd. (referred to as “Wohua Pharmaceutical“, 002107.SZ) Chairman Zhao Bingxian, known as “China’s Buffett”, was detained by relevant parties in early July 2023.
People familiar with the matter said that Zhao Bingxian had been in Hong Kong before, and company affairs were carried out by his “remote control” sister Zhao Caixia. After Zhao Bingxian returned to the mainland recently, he found that he had been “border controlled” when he left. He had a premonition of something unexpected and was controlled soon.
Wohua PharmaceuticalIt is a listed company focusing on the field of cardiovascular and cerebrovascular Chinese patent medicines. Official website information shows that the company was founded in 2003 and is headquartered in Weifang, Shandong. It is affiliated to Beijing CSI Wanrong Investment Group Co., Ltd. and its history can be traced back to Wanhetang Pharmacy during the Qianlong period of the Qing Dynasty.The company was established in Shenzhen in 2007securitiesListed on an exchange. Wohua Pharmaceutical owns a number of subsidiaries and is recognized as a high-tech enterprise.
According to the official website of Wohua Pharmaceutical, Zhao Bingxian was born in Beijing in November 1963. He graduated from Shanghai Jiao Tong University with a master’s degree in finance. He has nearly thirty years of experience in investment,mergers and acquisitions,ReorganizationListing and business management experience. “Capital Operation Theory” was published in January 1997, which was the first domestic book to systematically discuss capital operation and investment.bankHis monograph was named one of China’s top ten best-sellers in 1997. In 1991, he founded and served as chairman and president of Beijing CSI Wanrong Investment Group, chairman of Beijing CSI Wanrong Pharmaceutical Investment Group, and concurrently chairman of Shandong Wohua Pharmaceutical Technology Co., Ltd.Luolai lifeTechnology Co., Ltd. (Luolai life002293.SZ) Director, etc.
Because he has helped many companies successfully go public, Zhao Bingxian was called “China’s Buffett” by a reporter from the Wall Street Journal. In 2010, Zhao Bingxian was accused of domestic violence, extramarital affairs, etc., and he and his wife were involved in a divorce dispute, which caused a sensation.
Article 22 of the “Measures for the Administration of Information Disclosure of Listed Companies” stipulates that “the company’s holdingshareholderactual controllers, directors, supervisors, and senior managers are suspected of serious violations of disciplines and laws or official crimes and have been detained by the disciplinary inspection and supervision agencies and affect their performance of duties.” Listed companies should disclose immediately. However, as of now, Wohua Pharmaceutical has not announced relevant information Information about Zhao Bingxian’s detention.
The last information about Zhao Bingxian published by the companyannouncementIt’s on June 13, 2023. The announcement stated that recently, the company received a notice from the actual controller Zhao Bingxian and learned that the Tongzhou District People’s Court of Beijing made a first-instance judgment on the property dispute case between Zhao Bingxian and Lu Juan after their divorce on June 1, 2023. Among them, the first-instance judgment divided the equity held by both parties equally in the company’s controlling shareholder Beijing CSI Wanrong Investment Group Co., Ltd. However, the first-instance judgment had not yet taken effect, and Zhao Bingxian said he would appeal in accordance with the law.
On November 6, Jiemian News called the administrative department of Wohua Pharmaceutical. The other party said it was not aware of Zhao Bingxian’s detention and said it would make further inquiries before responding.
It is worth noting that on October 27, Zhao Bingxian served as directorLuolai lifeTechnology Co., Ltd. issued an announcement stating that Zhao Bingxian applied to resign from his position as director of the company’s sixth board of directors due to personal reasons. After resignation, he will no longer hold any position in the company.
(Article source: Jiemian News)
Article source: Jiemian News
Original title: Zhao Bingxian, the actual controller of Wohua Pharmaceutical and “China’s Buffett”, is suspected of being detained. The company: Don’t know
Solemnly declare:Oriental Fortune publishes this content to disseminate more information. It has nothing to do with the position of this site and does not constitute investment advice. Operate accordingly at your own risk.